NORBERTO
ORTEGO CENTENO
CATEDRÁTICO DE UNIVERSIDAD
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (29)
2023
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
2021
-
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
Nature Communications, Vol. 12, Núm. 1
-
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085
-
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
Scientific Reports, Vol. 11, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
Scientific Reports, Vol. 10, Núm. 1
-
Standardization procedure for flow cytometry data harmonization in prospective multicenter studies
Scientific Reports, Vol. 10, Núm. 1
2019
-
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
Journal of Clinical Medicine, Vol. 8, Núm. 11
2016
-
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway
Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus
Arthritis and Rheumatology
2013
-
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci
Human Molecular Genetics, Vol. 22, Núm. 19, pp. 4021-4029
-
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238
2012
-
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators
Arthritis and Rheumatism, Vol. 64, Núm. 1, pp. 264-271
-
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Arthritis Research and Therapy, Vol. 14, Núm. 3
-
Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis
Genes and Immunity, Vol. 13, Núm. 6, pp. 458-460
-
Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up
Human Molecular Genetics, Vol. 21, Núm. 12, pp. 2825-2835
-
Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression
Journal of Rheumatology, Vol. 39, Núm. 1, pp. 112-118